Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Phio Pharmaceuticals Corp. - Common Stock (NQ:PHIO)

1.835 -0.215 (-10.49%)
Streaming Delayed Price Updated: 3:45 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 160,382,069
Open 3.470
Bid (Size) 1.830 (2,500)
Ask (Size) 1.840 (3,200)
Prev. Close 2.050
Today's Range 1.720 - 4.190
52wk Range 0.9657 - 9.790
Shares Outstanding 5,726,750
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are the most active in today's session
Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity. 
Via Chartmill
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company... 
Via Newsfile

Performance

YTD
-3.4%
-3.4%
1 Month
-23.2%
-23.2%
3 Month
-22.6%
-22.6%
6 Month
-2.4%
-2.4%
1 Year
-42.8%
-42.8%

More News

Read More
Why Is Phio Pharmaceuticals Stock Soaring Today?
Via Benzinga
Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Gapping stocks in Monday's session
Via Chartmill
Discover the top movers in Monday's pre-market session.
Via Chartmill
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial
Via Newsfile
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director
Via Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Via Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Via Newsfile
Phio Pharmaceuticals to Present at the Life Sciences Future Conference
Via Newsfile
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Via Newsfile
Phio Posts Wider Loss in Fiscal Q2
Via The Motley Fool
Phio Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Via Newsfile
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds
Via Newsfile
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort
Via Newsfile
Gapping stocks in Friday's session
Via Chartmill
Friday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance
Via Newsfile
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort
Via Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Via Newsfile
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?
Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.
What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?
Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?
The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market
What is the current price of Phio Pharmaceuticals Corp. - Common Stock?
The current price of Phio Pharmaceuticals Corp. - Common Stock is 1.835
When was Phio Pharmaceuticals Corp. - Common Stock last traded?
The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 11/03/25 03:45 PM ET
What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?
The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 10.51M
How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?
Phio Pharmaceuticals Corp. - Common Stock has 11M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.